NeueHealth Accounts Payable vs Short Term Investments Analysis
| NEUE Stock | 5.07 0.12 2.42% |
NeueHealth financial indicator trend analysis is infinitely more than just investigating NeueHealth recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NeueHealth is a good investment. Please check the relationship between NeueHealth Accounts Payable and its Short Term Investments accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeueHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For information on how to trade NeueHealth Stock refer to our How to Trade NeueHealth Stock guide.
Accounts Payable vs Short Term Investments
Accounts Payable vs Short Term Investments Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NeueHealth Accounts Payable account and Short Term Investments. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between NeueHealth's Accounts Payable and Short Term Investments is 0.54. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of NeueHealth, assuming nothing else is changed. The correlation between historical values of NeueHealth's Accounts Payable and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of NeueHealth are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Accounts Payable i.e., NeueHealth's Accounts Payable and Short Term Investments go up and down completely randomly.
Correlation Coefficient | 0.54 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Accounts Payable
An accounting item on the balance sheet that represents NeueHealth obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of NeueHealth are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Short Term Investments
Short Term Investments is an item under the current assets section of NeueHealth balance sheet. It contains any investments NeueHealth undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that NeueHealth can easily liquidate in the marketplace.Most indicators from NeueHealth's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NeueHealth current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeueHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For information on how to trade NeueHealth Stock refer to our How to Trade NeueHealth Stock guide.At present, NeueHealth's Sales General And Administrative To Revenue is projected to slightly decrease based on the last few years of reporting.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 1.5B | 751.2M | 1.2B | 928.5M | Depreciation And Amortization | 35.0M | 30.7M | 18.3M | 20.6M |
NeueHealth fundamental ratios Correlations
Click cells to compare fundamentals
NeueHealth Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether NeueHealth is a strong investment it is important to analyze NeueHealth's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NeueHealth's future performance. For an informed investment choice regarding NeueHealth Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeueHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For information on how to trade NeueHealth Stock refer to our How to Trade NeueHealth Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeueHealth. If investors know NeueHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeueHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 145.939 | Quarterly Revenue Growth 0.286 | Return On Assets (0.04) | Return On Equity (1.83) |
The market value of NeueHealth is measured differently than its book value, which is the value of NeueHealth that is recorded on the company's balance sheet. Investors also form their own opinion of NeueHealth's value that differs from its market value or its book value, called intrinsic value, which is NeueHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeueHealth's market value can be influenced by many factors that don't directly affect NeueHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeueHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeueHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeueHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.